| Literature DB >> 28343737 |
Renuka Chowdhury1, Adrianne Tsen2.
Abstract
Cryoglobulinemia is a manifestation of hepatitis C virus (HCV) infection. Treatment of HCV is the mainstay of therapy for mixed cryoglobulinemia syndrome, and newer HCV therapies with direct-acting antiviral agents have achieved great success in treating HCV infection compared with pegylated interferon alfa and ribavirin. Recurrence of mixed cryoglobulinemia syndrome following successful treatment with direct-acting antiviral agents is uncommon, and when it occurs, it is most often due to relapse of HCV viremia. We report a case of recurrent mixed cryoglobulinemia syndrome following HCV treatment with a new direct-acting antiviral agent (sofosbuvir) and ribavirin, in which HCV RNA was undetectable in serum, but detectable in the cryoprecipitate.Entities:
Keywords: HCV RNA; Recurrent mixed cryoglobulinemia syndrome; case report; cryoprecipitate; direct antiviral agents; hepatitis C virus (HCV); kidney biopsy; membranoproliferative glomerulonephritis; renal involvement; sofosbuvir; sustained virological response (SVR); viral load
Mesh:
Substances:
Year: 2017 PMID: 28343737 DOI: 10.1053/j.ajkd.2017.01.041
Source DB: PubMed Journal: Am J Kidney Dis ISSN: 0272-6386 Impact factor: 8.860